MICB and neoplasm: Specifically, miR-10b and miR-20a have been found to downregulate MHC Class I chain-related A and B (MICA and MICB, respectively) ligands of the natural killer (NK) activating receptor, NKG2D, thus resulting in the suppression of innate immunity and subsequent tumor growth [12].